These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 9375948)

  • 21. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta blockers: evidence versus wishful thinking.
    Andresen D; Ehlers HC; Wiedemann M; Brüggemann T
    Am J Cardiol; 1999 Mar; 83(5B):64D-67D. PubMed ID: 10089842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management strategies in patients at high risk of sudden cardiac death following myocardial infarction.
    Sra J; Underwood RD; Akhtar M
    Indian Heart J; 1995; 47(2):158-62. PubMed ID: 7590846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1-adrenergic blockade and sudden cardiac death.
    Vanoli E; Hull SS; Foreman RD; Ferrari A; Schwartz PJ
    J Cardiovasc Electrophysiol; 1994 Jan; 5(1):76-89. PubMed ID: 7910510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular antiarrhythmic effects of beta-adrenergic blocking drugs: a review of mechanism and clinical studies.
    Pratt C; Lichstein E
    J Clin Pharmacol; 1982; 22(8-9):335-47. PubMed ID: 6127349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers and sudden cardiac death.
    Kendall MJ; Lynch KP; Hjalmarson A; Kjekshus J
    Ann Intern Med; 1995 Sep; 123(5):358-67. PubMed ID: 7625625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischaemic heart disease: how well are the risk profiles modulated by current beta blockers?
    Leren P
    Cardiology; 1993; 82 Suppl 3():8-12. PubMed ID: 8106167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.
    Anderson JL
    Control Clin Trials; 1996 Jun; 17(3 Suppl):17S-27S. PubMed ID: 8877264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials.
    Olsson G; Wikstrand J; Warnold I; Manger Cats V; McBoyle D; Herlitz J; Hjalmarson A; Sonneblick EH
    Eur Heart J; 1992 Jan; 13(1):28-32. PubMed ID: 1533587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function.
    Siu CW; Pong V; Jim MH; Yue WS; Ho HH; Li SW; Lau CP; Tse HF
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):675-80. PubMed ID: 20132502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.